SCHEMBL6901219

SCHEMBL6901219

CC1c2ccccc2C(=O)c2ccccc21

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDC25B P30305 3/20 0.52
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
EDNRB P24530 1/20 0.50
EDNRA P25101 1/20 0.50
MAPK1 P28482 2/20 0.47
CYP1A2 P05177 2/20 0.47
TYR P14679 1/20 0.46
KDM4E B2RXH2 2/20 0.43
LMNA P02545 2/20 0.43
POLB P06746 2/20 0.43
MAPT P10636 2/20 0.43
MAOA P21397 2/20 0.43
RAB9A P51151 2/20 0.43
BLM P54132 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
CES2 O00748 1/20 0.43
APAF1 O14727 1/20 0.43
TERT O14746 1/20 0.43
NPC1 O15118 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14178919 0.86 TYR (0.44) CDC25BMEN1KMT2AEDNRBEDNRA
SCHEMBL40599 0.84 GPR3 (0.52) MEN1KMT2ACYP1A2POLBBCHE
SCHEMBL29641604 0.84 GPR3 (0.52) MEN1KMT2ACYP1A2POLBBCHE
SCHEMBL12185953 0.82 ELANE (0.46) CDC25BMEN1KMT2AMAPK1CYP1A2
SCHEMBL21311997 0.79 ACHE (0.39) KMT2ATYRKDM4EMAPTMAOA
SCHEMBL6903914 0.79 MAPK1 (0.67) CDC25BMEN1KMT2AEDNRBEDNRA
SCHEMBL13892730 0.79 TYR (0.54) CDC25BMEN1KMT2AEDNRBEDNRA
SCHEMBL22879476 0.79 CES1 (0.58) MEN1KMT2ATYRKDM4EMAOA
SCHEMBL12179513 0.79 PTPRC (0.46) CDC25BMEN1KMT2AEDNRBEDNRA
Bicarbonate SCHEMBL4820941 0.78 HTR7 (0.50) MEN1KMT2AEDNRBEDNRACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5227560-A Vinylene or exomethylene groups from active methine compounds THE DOW CHEMICAL COMPANY (US) 1993-07-13 US claimed
US-20150344407-A1 FENDILINE DERIVATIVES AND METHODS OF USE THEREOF AVIARA PHARMACEUTICALS, INC. 2015-12-03 US disclosed
US-8974769-B2 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same CHANG GUNG UNIVERSITY (TW) 2015-03-10 US disclosed
US-8974769-B2 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same CHANG GUNG UNIVERSITY (TW) 2015-03-10 US disclosed
US-8653204-B2 Carboxylic polybenzimidazole CHANG GUNG UNIVERSITY (TW) 2014-02-18 US disclosed
US-8653203-B2 Method for preparing carboxylic polybenzimidazole CHANG GUNG UNIVERSITY (TW) 2014-02-18 US disclosed
US-8653203-B2 Method for preparing carboxylic polybenzimidazole CHANG GUNG UNIVERSITY (TW) 2014-02-18 US disclosed
US-8653204-B2 Carboxylic polybenzimidazole CHANG GUNG UNIVERSITY (TW) 2014-02-18 US disclosed
US-8318830-B2 Photolatent catalysts based on organometallic compounds BASF SE (DE) 2012-11-27 US disclosed
US-20120035333-A1 CARBOXYLIC POLYBENZIMIDAZOLE CHANG GUNG UNIVERSITY (TW) 2012-02-09 US disclosed
US-20120031774-A1 ELECTRODE FOR AN ELECTROCHEMICAL DEVICE AND METHOD FOR DETECTING HYDROGEN PEROXIDE USING THE ELECTRODE CHANG GUNG UNIVERSITY (TW) 2012-02-09 US disclosed
US-20120035333-A1 CARBOXYLIC POLYBENZIMIDAZOLE CHANG GUNG UNIVERSITY (TW) 2012-02-09 US disclosed
US-20120031774-A1 ELECTRODE FOR AN ELECTROCHEMICAL DEVICE AND METHOD FOR DETECTING HYDROGEN PEROXIDE USING THE ELECTRODE CHANG GUNG UNIVERSITY (TW) 2012-02-09 US disclosed
US-20120035334-A1 METHOD FOR PREPARING CARBOXYLIC POLYBENZIMIDAZOLE CHANG GUNG UNIVERSITY (TW) 2012-02-09 US disclosed
US-20120035334-A1 METHOD FOR PREPARING CARBOXYLIC POLYBENZIMIDAZOLE CHANG GUNG UNIVERSITY (TW) 2012-02-09 US disclosed
US-20110104077-A1 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same CHANG GUNG UNIVERSITY (TW) 2011-05-05 US disclosed
US-20110104077-A1 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same CHANG GUNG UNIVERSITY (TW) 2011-05-05 US disclosed
US-20100234485-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS BASF SE (DE) 2010-09-16 US disclosed
US-6815481-B2 FUSED DIBENZO THERMAL STABILIZERS SUCH AS ANTHRACENE, XANTHENE AND ANTHRONE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2004-11-09 US disclosed
US-20020032256-A1 Polybutadiene composition SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2002-03-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234485-A1 PHOTOLATENT CATALYSTS BASED ON ORGANOMETALLIC COMPOUNDS PUF60, TST, MPST CDC25B 2213/4885MEN1 2899/4885KMT2A 103/4885
US-20150344407-A1 FENDILINE DERIVATIVES AND METHODS OF USE THEREOF KRAS, RASSF5, RASSF2 CDC25B 1598/4885MEN1 760/4885KMT2A 3273/4885
US-20110104077-A1 Magnetic nanocomposite with multi-biofunctional groups and method for fabricating the same CD47, EPCAM, MB CDC25B 3938/4885MEN1 132/4885KMT2A 799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.